Category: BPH (UROLOGY)
Product Description
Flowel® contains Tamsulosin Hydrochloride 0.4 mg in an extended-release (ER) formulation. Tamsulosin is a selective α1A-adrenergic receptor antagonist that relaxes the smooth muscles of the prostate, bladder neck, and urethra, thereby improving urinary flow and relieving lower urinary tract symptoms (LUTS) associated with Benign Prostatic Hyperplasia (BPH).
Its uroselective action provides effective symptom relief with minimal effects on blood pressure, making Flowel® a preferred option for the medical management of BPH.
Indications
Flowel® is indicated for:
- Treatment of the signs and symptoms of Benign Prostatic Hyperplasia (BPH)
- Relief of lower urinary tract symptoms (LUTS), including:
- Difficulty initiating urination
- Weak urinary stream
- Intermittent urine flow
- Urinary frequency
- Urgency
- Nocturia
- Sensation of incomplete bladder emptying
- Improvement of urinary flow rate and quality of life in patients with BPH
Contraindications
Flowel® is contraindicated in patients with:
- Hypersensitivity to Tamsulosin Hydrochloride or any component of the formulation.
- History of orthostatic hypotension.
- Severe hepatic impairment.
Use with caution in patients with severe renal impairment and in those scheduled for cataract or glaucoma surgery due to the risk of Intraoperative Floppy Iris Syndrome (IFIS).
Dosage and Administration
Adults
- One 0.4 mg extended-release capsule once daily, preferably 30 minutes after the same meal each day.
- Swallow the capsule whole with water.
- Do not crush, chew, or open the capsule.
Elderly Patients
- No dosage adjustment is generally required.
Duration of Therapy
Flowel® is intended for long-term treatment and should be continued as prescribed to maintain symptom control.
Key Features
- Selective α1A-adrenergic receptor blocker
- Relieves lower urinary tract symptoms associated with BPH
- Improves urinary flow and bladder emptying
- Extended-release formulation for consistent symptom control
- Once-daily dosing for improved patient adherence
- Minimal effect on systemic blood pressure
- Rapid onset of symptomatic relief